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The European heatwave of 2003 showed the potentially 
disastrous eﬀ ects of heatwaves. About 70 000 premature 
deaths resulted, notably in France, and a series of 
lethal heatwaves have subsequently occurred in several 
countries.1 However, less well appreciated is the similar 
burden of mortality from moderately hot weather, which, 
depending on deﬁ nitions, could  be greater than that of 
mortality attributable to extreme heat in some places.2
Evidence is accumulating about the health risks of 
abnormal ambient temperatures. Conventionally, studies 
either focus on the eﬀ ects of extreme temperature events, 
or aim to deﬁ ne exposure–response associations between 
temperature and mortality.1,2 However, whether data that 
are collected at country, or even city, level are relevant to 
other climatic settings is doubtful. Moreover, a focus on 
extreme weather (such as heatwaves) might ignore the 
incremental risk of moderately unusual temperatures. 
Both high and low temperatures have been reported to 
be associated with mortality and morbidity from causes 
such as cardiovascular disease and respiratory disease.3 
Although deaths attributable to cold are substantially 
more common in most places than are those attributable 
to heat, they attract far less public attention.3
In The Lancet, Antonio Gasparrini and colleagues4 use a 
very large multicountry database and novel methods to 
present a quantitative analysis of the attributable risk of 
ambient temperature for mortality. They collected data 
for daily mortality, temperature, and other confounding 
variables from 13 countries, which included more than 
74 million deaths recorded in 384 locations across 
temperate and tropical climates (roughly a third of 
locations were in the USA). The investigators analysed 
the data with a time series quasi-Poisson model to 
obtain the cumulative exposure–response association 
of temperature and mortality for each location. 
The total eﬀ ect of a given day’s temperature on the 
death rate was deﬁ ned as the sum of the eﬀ ect on 
that day and 21 subsequent days. These associations 
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predicted). With evidence of clinical eﬃ  cacy now shown, 
use of augmentation treatment earlier than at present, 
before onset of decline in lung function, should be 
explored. Diagnosis of α1 antitrypsin deﬁ ciency is a 
single blood test, and the data7 would suggest that 
treatment could begin earlier and lung parenchymal 
destruction could be prevented.
Finally, the challenge remains of a means to 
augment α1 antitrypsin concentrations in patients 
with α1 antitrypsin deﬁ ciency without the need 
for intravenous infusions every week, and to do so 
in a less costly manner (present treatment costs 
US$ 100 000 per individual per year). We10,11 and 
others12 are therefore exploring gene therapy strategies 
to augment α1 antitrypsin concentrations using 
adeno-associated viral gene transfer vectors, a treatment 
that can potentially replace α1 antitrypsin augmentation 
with a single administration.
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were adjusted for average temperature, range of 
temperature, and country indicator; the minimum 
mortality temperature—or optimum temperature—and 
the fraction of deaths attributable to non-optimum 
temperature were calculated for each country. The 
eﬀ ect on mortality was divided into cold versus heat, 
and moderate versus extreme. 
Gasparrini and colleagues4 report that, ﬁ rst, 
cold-related deaths outnumbered heat-related 
deaths by a factor of nearly 20, overall. Second, 
deaths attributable to moderately non-optimum 
temperatures substantially outnumbered those 
attributable to extreme temperatures; and third, 
the minimum mortality temp erature was usually 
well above the median temperature. In the study, 
most attributable deaths were associated with cold 
(7·29%, 95% empirical CI 7·02–7·49), while only 0·42% 
(0·39–0·44) of deaths were attributable to heat, a 
large disparity between the eﬀ ects of high and low 
temperatures compared with previous studies.5,6 
The investigators mention that their results could 
be extended to projections of temperature-related 
mortality in climate-change scenarios. In 2014, the 
Intergovernmental Panel on Climate Change7 reported 
that, although climate change will lead to an increase 
in heat-related mortality and a decrease in cold-related 
mortality in some parts of the world, the current health 
burden of climate change was insuﬃ  ciently known and 
the magnitude of such eﬀ ects had not been addressed 
globally. The high proportion of deaths attributable 
to cold rather than heat seems to oﬀ er an alternative 
perspective on global warming and human health. 
However, if—as the data seem to show—extreme cold is 
relatively unimportant, then a few degrees of warming 
will not yield a large reduction in cold-related mortality. 
Moreover, if extreme heat is important, then the same 
few additional degrees might cause a substantial 
increase in heat-related mortality.8,9
Gasparrini and colleagues4 also report that moderately 
non-optimum temperatures accounted for nearly 7% 
of the overall mortality, while extreme temperatures 
accounted for less than 1%, which suggests that eﬀ orts 
related to adaptation to temperature risk should focus 
on moderate non-optimum conditions instead of 
record-breaking weather. However, this ﬁ nding applies 
more to cold than to heat, and, crucially, depends 
on the deﬁ nition of extreme. The deﬁ nition used by 
Gasparrini and colleagues for extreme cold was daily 
average temperature less than the 2·5th percentile for 
each location, while they used the 97·5th percentile to 
deﬁ ne extreme heat. Because the minimum mortality 
temperature tends to be near the 80th or even 90th 
percentile, extreme heat occurs on a large proportion—
possibly as many as a quarter—of days that have 
temperatures higher than the minimum mortality 
temperature, while extreme cold occurs on a much 
smaller fraction of cool days—only about one in 30. 
Moreover, the mortality–temperature response functions 
tend to become increasingly steep at high temperatures, 
but become less steep at low temperatures in most 
places, with London, UK, and Madrid, Spain, being 
notable exceptions. Overall, deaths attributable 
to extreme heat are roughly as frequent as those 
attributable to moderate heat, while those attributable 
to extreme cold are negligible compared with those 
caused by moderate cold. To address the diﬀ erent risks 
for heat and cold and to develop adaptation strategies 
according to local conditions, it would be more helpful to 
treat the two extremes separately.
The reported results4 have remarkably narrow 
conﬁ dence intervals: eg, the overall mortality attributed 
to non-optimum temperature was reported to be 7·71% 
(95% empirical CI 7·43–7·91). Although such narrow 
conﬁ dence intervals reﬂ ect the very large dataset used, 
it is worth considering what random process gave rise to 
this minimum uncertainty, and whether other random 
inputs that would increase it have been ignored. In fact, 
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data, and so show only the random (Poisson-distributed) 
occurrence of deaths in these locations over the measured 
time spans. As the investigators explain, their results are 
not globally representative, so should be interpreted 
with caution when applied to other regions that were not 
included in the database, especially by policy makers. How 
representative the results are of temperature-attributable 
mortality worldwide would be interesting to know. The 
CIs would certainly be much wider if the analysis took 
into account the process of sampling countries, but the 
main results might still be robust.
Other limitations exist, and further work is needed. 
As Gasparrini and colleagues4 admit, factors such as 
susceptibility or resilience have not been included in 
the analysis, including socioeconomic status, age, and 
confounding air pollutants.10 For example, although 
the authors used each country as a proxy to control 
for regional characteristics in the meta-analysis, the 
reported total attributable mortality fraction of each 
country is still positively associated with the proportion 
of the population aged 60 years or older in 2013.11 
China and Sweden are exceptions to the trend, possibly 
because of their extreme population and development 
situations. Since high or low temperatures aﬀ ect 
susceptible groups such as unwell, young, and 
elderly people the most,12–14 attempts to mitigate 
the risk associated with temperature would beneﬁ t 
from in-depth studies of the interaction between 
attributable mortality and socioeconomic factors, to 
avoid adverse policy outcomes and achieve eﬀ ective 
adaptation. Nonetheless, despite these limitations, the 
methods and results of Gasparrini and colleagues’ study 
set a benchmark and starting point for future research.
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